Blog

CEO views

Reflecting on UKRI’s first five year strategy

In this blog post for the BioIndustry Association, our CEO reflects on UK Research and Innovation's 2022 strategy.

05.05.2022

Published by BIA

In this blog post for the BioIndustry Association, our CEO reflects on UK Research and Innovation's 2022 strategy.

Published by BIA

Read now

expert opinion

Addressing current challenges of in vitro cell models

In this blog, learn about current challenges of hiPSC-derived cell models, best approach for cell generation & future trends for h...

31.03.2022

Published by bit.bio

Read now

CEO views

SynBio: the opportunity for UK Life Sciences

Our CEO writes about the importance of the synthetic biology industry as part of the UK Life Sciences vision. This was first publi...

04.03.2022

Published by BIA

Read now

technology

Giving you easy access to endless and reliable human cells

Read this blog to learn how bit.bio are offering easy access to endless and reliable human cells for research and drug discovery.

08.10.2021

Published by bit.bio

Read now

CEO views

Business and academia - the perfect partners to achieve SDGs

Our CEO reflects on a recent UN High-Level Political Forum discussion about industry & academia collaborations to achieve sustaina...

27.07.2021

Published by Medium

Read now

CEO views

Why did I start a healthcare and cultured meat company?

Our CEO explains how our opti-ox technology underpins not only bit.bio but also Meatable - a cultured meat company — and why we ne...

26.04.2021

Published by Medium

Read now

Related pages